• Location: Vancouver, Canada (Open to Relocation/Remote)
• Compensation Expectations: Open to discussion based on role scope (Targeting Director/VP Level) • Visa Status: Canadian Citizen
• Recruiter Note: This candidate is a unique "hybrid" executive—a scientist by training (9 years in R&D) who transitioned into high-stakes commercial leadership (Ivy League MBA). He is currently a Director of Business Development, managing a complex B2G sales cycle, looking to return to his roots in Biotech/Life Sciences.
Executive combining an Ivy League MBA with a BSc in Biology and 9 years of research background, including the development of IP for diabetes and oncology. His diverse career encompasses Sales and Operations leadership in both early-stage startups and established enterprise software companies, where he has successfully sold B2B SaaS and complex enterprise solutions to government and public-sector organizations across EMEA, the Americas, and Oceania.
Uniquely, he also served as a COO in the hospitality sector, earning a Michelin Star for operational excellence in international markets. Bridging the gap between scientific innovation and commercial execution, he leverages his technical expertise to navigate high-stakes deals totaling up to $19.7M, making him an ideal strategic leader in the Biotech and Life Sciences industry.
• Architected and executed a rapid growth strategy as COO for a B2B SaaS startup, optimizing operations for scale.
• Led B2G IT sales and expansion across 3 business units, navigating complex regulations in North America and EMEA.
• Developed IP for diabetes and oncology; led mRNA/siRNA vaccine research projects.
• Drove 312% growth in Managed Services accounts (from 8 to 33 in 26 months).
• Managed 350+ staff, scaling a 12-establishment group and launching a 6,700 sq ft venue.
• COO (Hospitality) Earned Michelin Star recognition (2017), led 350 staff, and expanded operations from 8 to 12 locations in one year.
• Type of Solutions & Users Supported: Deep experience with IT & Biotech. He understands the "user journey" of a bench scientist because he was one for nearly a decade, and he knows how to sell complex IT solutions in regulated markets.
• Scope of Roles Held: Hybrid commercial leadership combining Strategic Sales, Business Development, and Operations. He has led international expansion strategies across North America, Europe, and the Middle East.
• R&D Context: The candidate didn't just sell to labs; he ran them. He spent 9 years in pre-clinical drug formulation, mRNA/siRNA vaccine research, and assay design.
• IP Development: He is a credited contributor to intellectual property for diabetes, obesity, IBS, and colon cancer treatments, giving him instant credibility with scientific stakeholders.
• Complex Sales Cycles: Expert in navigating bureaucratic buying committees. His current role involves winning contracts with government bodies (State/Provincial levels), which mirrors the complexity of selling to large Pharma/Enterprise R&D.
• White-Glove Service: As a former COO who earned a Michelin Star, he brings an elite level of client service. He leverages this diverse success to "lead from experience," setting high standards for his teams.
• Global Vertical Market Software Company | Director of Business Development (2022 – Present)
• B2B SaaS Startup | Chief Operating Officer (2021)
• Global Technology Services Provider | Operations Manager (2018 – 2020)
• International Hospitality Group | Chief Operating Officer (2016 – 2017)
• Catering & Hospitality Venture | Managing Partner & Cofounder (2012 – 2016)
• Biotechnology Research Firm | Research Manager (2005 – 2011)
• Academic Research Centre | Research Assistant (2001 – 2004)
• Master of Business Administration (MBA) | Ivy League University
• Bachelor of Science in Biology | Top-Tier Canadian University
